Characterization liver low Michaelis-Menten constant adenosine monophosphate phosphodiesterase activity status studies subcellular distribution biochemical properties hepatic cAMP phosphodiesterase activity thyroid status rat Thyroidectomy increase low Michaelis-Menten constant Km cAMP phosphodiesterase activity Golgi-endosomal fractions activity crude particulate fractions analytical sucrose density gradients increase cAMP phosphodiesterase activity particulate elements densities Acute insulin treatment increase cAMP phosphodiesterase activity Golgi-endosomal fractions thyroidectomized rats cAMP phosphodiesterase activity Golgi-endosomal fraction euthyroid hypothyroid rats cGMP microM microM Activity griseolic acid cilostamide cilostazole microM sensitive mM Treatment Golgi-endosomal fractions hypotonic extract rat liver solubilization low Km cAMP phosphodiesterase activity sucrose density gradients solubilized activity asymmetrical peak sedimentation coefficient euthyroid rats hypothyroid rats polyacrylamide gel electrophoresis activity majors Rf values activity fast-moving peak thyroidectomy diethylaminoethyl-Sephacel chromatography peaks cAMP phosphodiesterase activity cGMP-inhibitable Thyroidectomy activity cGMP-inhibitable peaks sodium acetate appearance new peak activity sensitive results low Km phosphodiesterase activity liver Golgi-endosomal fractions hyperinsulinemic rats hypothyroid animals pharmacological physical criteria enzyme species thyroid status cGMP-and cilostamide-inhibited subclass low Km cAMP phosphodiesterases 